| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/25/2007 | CN1951430A Compound Chinese medicine for treating psoriasis and lupus erythematosus |
| 04/25/2007 | CN1951409A Medicinal composition containing propolis, preparation method and use thereof |
| 04/25/2007 | CN1951401A Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 04/25/2007 | CN1951400A Arenobufagin nanoliposome and preparation method thereof |
| 04/25/2007 | CN1951396A Effective part of sweet wormwood, its preparation method and application thereof in pharmacy |
| 04/25/2007 | CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 04/25/2007 | CN1951388A Betamethasone sodium phosphate powder injection and preparation method thereof |
| 04/25/2007 | CN1312271C Method of whole manual culture for chinese caterpillar fungus |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312171C DNA vaccines encoding HIV accessory proteins |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312135C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 04/25/2007 | CN1312125C Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 04/25/2007 | CN1312120C Adamantane derivatives |
| 04/25/2007 | CN1311855C Officinal Dendrobium stem capsule and preparing method |
| 04/25/2007 | CN1311829C Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins |
| 04/24/2007 | US7208655 A plant virus containing a predetermined foreign peptide as part of the coat protein of the virus |
| 04/24/2007 | US7208629 5′-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208527 Potassium channel modulators |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 04/24/2007 | US7208478 Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/24/2007 | US7208279 Method for identifying inhibitors of G protein coupled receptor signaling |
| 04/24/2007 | US7208156 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 04/24/2007 | US7208155 Agent for treating allergic or hypersensitivity condition |
| 04/24/2007 | US7208147 Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2184345C Coordinate in vivo gene expression |
| 04/24/2007 | CA2141951C Inhibition of retrovirus infection |
| 04/24/2007 | CA2131644C Quinoline compounds |
| 04/24/2007 | CA2106827C Pharmaceutical compositions containing cyclosporins |
| 04/24/2007 | CA2091346C Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/24/2007 | CA2075173C Compounds and methods for inhibition of hiv and related viruses |
| 04/19/2007 | WO2007043652A1 2-thienylurea derivative |
| 04/19/2007 | WO2007043630A1 Nkt cell-stimulating agent for administration through upper respiratory tract mucous membrane |
| 04/19/2007 | WO2007043433A1 Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
| 04/19/2007 | WO2007043426A1 Dermatitis remedies |
| 04/19/2007 | WO2007043287A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR Ϝ-CHAIN |
| 04/19/2007 | WO2007042554A2 Methods and compositions for treating immune disorders |
| 04/19/2007 | WO2007042299A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | WO2007042298A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | WO2007042289A2 Nanobodies™ and polypeptides against egfr and igf-ir |
| 04/19/2007 | WO2007041969A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 04/19/2007 | WO2007009233A3 Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases |
| 04/19/2007 | WO2006133398A3 In vitro activated donor t-cells to promote transplant engraftment |
| 04/19/2007 | WO2006111296A3 Dosage forms and combined preparations of pyrimidine biosynthesis inhibitors for achieving additional effects upon the immune system |
| 04/19/2007 | WO2006084210A3 Hif modulating compounds and methods of use thereof |
| 04/19/2007 | WO2006077471A3 Combining therapies targeting multiple toll-like receptors and use thereof |
| 04/19/2007 | WO2006012779A8 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070088087 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088020 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/19/2007 | US20070087963 Synthesis of cyclosporin analogs |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087010 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 04/19/2007 | US20070086993 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 04/19/2007 | CA2625488A1 Methods and compositions for treating immune disorders |
| 04/19/2007 | CA2625109A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 04/19/2007 | CA2624909A1 Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease |
| 04/19/2007 | CA2624781A1 Nanobodies tm and polypeptides against egfr and igf-ir |
| 04/19/2007 | CA2623109A1 Compositions and methods for treating proliferative disorders |
| 04/18/2007 | EP1775305A2 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 04/18/2007 | EP1775298A1 Thienopyrazole derivative having pde7 inhibitory activity |
| 04/18/2007 | EP1775286A1 Novel anandamide amidase inhibitors as analgesic agents |
| 04/18/2007 | EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/18/2007 | EP1773988A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/18/2007 | EP1773394A2 Antagonizing interleukin-21 receptor activity |
| 04/18/2007 | EP1773393A2 Preventing autoimmune disease by using an anti-cd20 antibody |
| 04/18/2007 | EP1773392A2 Method for preventing and treating mast cell mediated diseases |
| 04/18/2007 | EP1773333A1 Composition for the prevention and treatment of allergic inflammatory disease |
| 04/18/2007 | EP1773307A1 Compound formulations of 2-amino-1,3-propanediol compounds |
| 04/18/2007 | EP1567171B1 Use of dextran sulfate for treating ibmir |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1455792B1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 04/18/2007 | EP1411977B1 Composition containing bacterial antigens, used for the prophylaxis and the treatment of allergic diseases |
| 04/18/2007 | EP1392313B1 Combination comprising n- 5- 4-(4-methyl-piperazino-methyl)-benzoylamido|-2-methylphenyl -4-(3-pyridyl)-2pyrimidine-amine and a biphosphonate |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1343525B1 IMPROVED i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VACCINE |
| 04/18/2007 | EP1300405B1 Amino alcohol derivatives |
| 04/18/2007 | EP1283720B1 Recombinant or purified polyclonal antibodies for treating allergy |
| 04/18/2007 | EP1248645B1 Novel chimeric proteins and their use |
| 04/18/2007 | EP1204420B1 Trehalose producing prokaryotic cells as vaccines |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | EP1144010B1 Prevention of chronic graft rejection by a combination of immunotoxins and costimulation blockers |
| 04/18/2007 | EP1140166B1 Adjuvant containing N-formyl methionyl peptides for vaccines |
| 04/18/2007 | EP1005374B1 Microparticles for delivery of nucleic acid |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0956865B1 MEDICINES COMPRISING Rho KINASE INHIBITOR |
| 04/18/2007 | CN1950399A Less immunogenic binding molecules |
| 04/18/2007 | CN1950360A Substituted pyrrole-2, 5-diones as protein kinase c inhibitors |
| 04/18/2007 | CN1948475A Recombination expression carrier for treating Aids, reformed blood building stem cell and method |
| 04/18/2007 | CN1948332A Glycyrrhetinic acid-30-acylamide derivatives and its use |
| 04/18/2007 | CN1947731A Pearl products |
| 04/18/2007 | CN1947704A Medicinal water-soluble compositions contg. 20(R)-ginsenoside (Rg3), and its prepn. method |
| 04/18/2007 | CN1947692A Artificial compound black mud |